Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 8664980)

Published in Eur J Endocrinol on May 01, 1996

Authors

T Chevalley1, D D Strong, S Mohan, D Baylink, T A Linkhart

Author Affiliations

1: Department of Medicine, Loma Linda University, CA, USA.

Articles by these authors

Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol (1987) 3.28

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med (2000) 3.16

Synthesis, Fourier transform infrared and Raman spectra, assignments and analysis of N-(phenyl)- and N-(chloro substituted phenyl)-2,2-dichloroacetamides. Spectrochim Acta A Mol Biomol Spectrosc (2004) 3.04

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev (1997) 2.63

Myogenic differentiation in permanent clonal mouse myoblast cell lines: regulation by macromolecular growth factors in the culture medium. Dev Biol (1981) 2.20

Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab (1998) 2.17

Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone (1997) 2.09

Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus. J Bacteriol (1987) 1.94

The amino acid sequence of the alpha-chain of human fibrinogen. Nature (1979) 1.92

Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A (2000) 1.90

Control of mouse myoblast commitment to terminal differentiation by mitogens. J Supramol Struct (1980) 1.89

A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J Immunol Methods (2003) 1.87

UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable. J Biol Chem (1993) 1.72

Nucleotide sequence, organisation and structural analysis of the products of genes in the nirB-cysG region of the Escherichia coli K-12 chromosome. Eur J Biochem (1990) 1.66

Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology (1998) 1.66

Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab (1994) 1.63

TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem (1999) 1.62

Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone (1996) 1.53

Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int (2000) 1.52

Formation, mineralization, and resorption of bone in vitamin D-deficient rats. J Clin Invest (1970) 1.48

INFORMAS (International Network for Food and Obesity/non-communicable diseases Research, Monitoring and Action Support): overview and key principles. Obes Rev (2013) 1.46

Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. Biochemistry (1982) 1.45

Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum (1993) 1.42

The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res (1999) 1.42

FTIR and FTRaman spectra, assignments, ab initio HF and DFT analysis of 4-nitrotoluene. Spectrochim Acta A Mol Biomol Spectrosc (2010) 1.41

Nuclear entry of nonviral vectors. Gene Ther (2005) 1.40

Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg (2001) 1.38

Antibodies against synthetic peptides reveal that the unidentified reading frame A6L, overlapping the ATPase 6 gene, is expressed in human mitochondria. Cell (1983) 1.37

Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36

Identification of transcription activators that regulate gonococcal adaptation from aerobic to anaerobic or oxygen-limited growth. Mol Microbiol (2000) 1.36

Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35

Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population. Genome Res (2001) 1.35

Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab (1996) 1.34

Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest (2001) 1.32

Estrogen receptor specificity in the regulation of the skeleton in female mice. J Endocrinol (2001) 1.31

Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice. J Bone Miner Res (2001) 1.31

gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. Proc Natl Acad Sci U S A (1982) 1.30

Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology (2001) 1.28

Isolation, characterization, and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle. Biochemistry (1982) 1.28

Chyluria presenting as milky urine and nephrotic-range proteinuria. Kidney Int (2006) 1.27

Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol (1998) 1.27

Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology (1999) 1.27

The insulin-like growth factor system and the coupling of formation to resorption. Bone (1995) 1.24

Impact of ultrasonography on central venous catheter insertion in intensive care. Indian J Radiol Imaging (2009) 1.24

Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24

Monitoring the price and affordability of foods and diets globally. Obes Rev (2013) 1.22

Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J Cell Physiol (1988) 1.22

2-[(E)-(4-Chlorophenyl)methyleneamino]-N-(X-methylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide, where X = 2 and 3. Acta Crystallogr C (2004) 1.21

Monitoring the impacts of trade agreements on food environments. Obes Rev (2013) 1.18

Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology (1999) 1.16

Lamprey fibrinogen gamma chain: cloning, cDNA sequencing, and general characterization. Biochemistry (1985) 1.16

Quantitative trait loci for bone density in mice: the genes determining total skeletal density and femur density show little overlap in F2 mice. Calcif Tissue Int (2002) 1.16

Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant (2014) 1.15

Complementary DNA sequence of lamprey fibrinogen beta chain. Biochemistry (1986) 1.15

High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone (2008) 1.14

Production and release of acetylcholinesterase by cultured chick embryo muscle. Dev Biol (1973) 1.14

Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. J Clin Endocrinol Metab (1998) 1.13

Genetic control of the rate of wound healing in mice. Heredity (Edinb) (2001) 1.13

Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res (1999) 1.12

Growth factors to stimulate bone formation. J Bone Miner Res (1993) 1.11

Analysis of gene expression in the wound repair/regeneration process. Mamm Genome (2001) 1.10

Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab (1998) 1.10

Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab (1993) 1.10

Studies on the potential mediators of skeletal changes occurring during puberty in girls. J Clin Endocrinol Metab (1999) 1.09

Antigen trafficking and accessory cell function in respiratory epithelial cells. Am J Respir Cell Mol Biol (1999) 1.08

Monitoring and benchmarking government policies and actions to improve the healthiness of food environments: a proposed Government Healthy Food Environment Policy Index. Obes Rev (2013) 1.07

Monitoring the health-related labelling of foods and non-alcoholic beverages in retail settings. Obes Rev (2013) 1.07

Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors (1990) 1.07

Effect of calcitonin on the rates of bone formation and resorption in the rat. Endocrinology (1969) 1.07

Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice. Bone (2007) 1.06

Identification of the polypeptides encoded in the ATPase 6 gene and in the unassigned reading frames 1 and 3 of human mtDNA. Proc Natl Acad Sci U S A (1983) 1.06

Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter. Genes Brain Behav (2007) 1.05

Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta (1988) 1.04

Formation, mineralization, and resorption of bone in hypophosphatemic rats. J Clin Invest (1971) 1.03

Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. Biochem Biophys Res Commun (2000) 1.03

CNS cavernous haemangioma: "popcorn" in the brain and spinal cord. Clin Radiol (2011) 1.03

Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice. Bone (1998) 1.03

Quantitation of growth factors IGF-I, SGF/IGF-II, and TGF-beta in human dentin. J Bone Miner Res (1990) 1.02

Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab (2001) 1.02

T-box 3 negatively regulates osteoblast differentiation by inhibiting expression of osterix and runx2. J Cell Biochem (2009) 1.01

Amino acid sequence studies on the alpha chain of human fibrinogen. Overlapping sequences providing the complete sequence. Biochemistry (1979) 1.01

Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int J Urol (1996) 1.01

Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology (1989) 1.00

Decreased bone formation, mineralization, and enhanced resorption in calcium-deficient rats. Am J Physiol (1973) 0.99

Fitness, training, and the growth hormone-->insulin-like growth factor I axis in prepubertal girls. J Clin Endocrinol Metab (2001) 0.99

Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun (1991) 0.99

Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch Biochem Biophys (2000) 0.99

Quantitative trait loci for periosteal circumference (PC): identification of single loci and epistatic effects in F2 MRL/SJL mice. Bone (2003) 0.99

Mutations of an epitope hot-spot residue alter rate limiting steps of antigen-antibody protein-protein associations. Biochemistry (2001) 0.98

Effect of brief exercise on circulating insulin-like growth factor I. J Appl Physiol (1985) (1994) 0.97

Monitoring the levels of important nutrients in the food supply. Obes Rev (2013) 0.97

Structure-function analysis of the human insulin-like growth factor binding protein-4. J Biol Chem (1998) 0.97

The skeletal responsiveness to mechanical loading is enhanced in mice with a null mutation in estrogen receptor-beta. Am J Physiol Endocrinol Metab (2007) 0.97

Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts. Growth Horm IGF Res (2005) 0.96

Non-classical presentation of congenital cholesteatoma. Ann R Coll Surg Engl (2007) 0.96

Differential protein profile in the ear-punched tissue of regeneration and non-regeneration strains of mice: a novel approach to explore the candidate genes for soft-tissue regeneration. Biochim Biophys Acta (2000) 0.96